[go: up one dir, main page]

MX2010003486A - Cebadores de polinucleotido. - Google Patents

Cebadores de polinucleotido.

Info

Publication number
MX2010003486A
MX2010003486A MX2010003486A MX2010003486A MX2010003486A MX 2010003486 A MX2010003486 A MX 2010003486A MX 2010003486 A MX2010003486 A MX 2010003486A MX 2010003486 A MX2010003486 A MX 2010003486A MX 2010003486 A MX2010003486 A MX 2010003486A
Authority
MX
Mexico
Prior art keywords
polynucleotide primers
pik3ca mutations
detecting
detecting pik3ca
primers
Prior art date
Application number
MX2010003486A
Other languages
English (en)
Inventor
Ruth Board
Jennifer Ferguson
Paul Francis Ravetto
Nicola Jo Thelwell
David Whitcombe
Original Assignee
Dxs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dxs Ltd filed Critical Dxs Ltd
Publication of MX2010003486A publication Critical patent/MX2010003486A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Un polinucleótido que comprende al menos los seis nucleótidos finales de una de las siguientes secuencias de cebadores, o una secuencia complementaria a la misma: SEQ. lD NOS. 3 a 16, 18, 20 a 33, 35 á 37 a 39.
MX2010003486A 2007-09-28 2008-09-29 Cebadores de polinucleotido. MX2010003486A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0719034A GB2453173A (en) 2007-09-28 2007-09-28 Polynucleotide primers
PCT/GB2008/003306 WO2009040557A2 (en) 2007-09-28 2008-09-29 Polynucleotide primers for detecting pik3ca mutations

Publications (1)

Publication Number Publication Date
MX2010003486A true MX2010003486A (es) 2010-08-09

Family

ID=38701889

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010003486A MX2010003486A (es) 2007-09-28 2008-09-29 Cebadores de polinucleotido.

Country Status (13)

Country Link
US (4) US8901285B2 (es)
EP (7) EP2205760B1 (es)
JP (1) JP5719593B2 (es)
KR (4) KR101543214B1 (es)
CN (4) CN102119222B (es)
AU (1) AU2008303400B2 (es)
BR (1) BRPI0817444A2 (es)
CA (2) CA2700710C (es)
ES (6) ES2532141T3 (es)
GB (1) GB2453173A (es)
MX (1) MX2010003486A (es)
RU (1) RU2491289C2 (es)
WO (1) WO2009040557A2 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10190171B2 (en) 2007-09-28 2019-01-29 Qiagen Manchester Limited Polynucleotide primers for detecting PIK3CA mutations

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3246332B1 (en) * 2010-01-12 2019-07-10 Siemens Healthcare Diagnostics Inc. Oligonucleotides and methods for detecting pik3ca mutations
JP2013081450A (ja) * 2011-09-27 2013-05-09 Arkray Inc 多型検出用プローブ、多型検出方法、薬効判定方法及び多型検出用試薬キット
CN102453765B (zh) * 2011-11-03 2013-07-24 厦门艾德生物医药科技有限公司 Pik3ca基因驱动突变的检测探针、引物及试剂盒
HK1200723A1 (en) 2012-03-29 2015-08-14 Novartis Ag Pharmaceutical diagnostic
CN102816839A (zh) * 2012-07-06 2012-12-12 杭州艾迪康医学检验中心有限公司 用于检测结直肠癌pik3ca基因热点突变位点的试剂盒
EP2711432A1 (en) * 2012-09-21 2014-03-26 Genomica S.A.U. Method for detection of BRAF and PI3K mutations
ES2691306T3 (es) * 2013-03-13 2018-11-26 F. Hoffmann-La Roche Ag Procedimientos y composiciones para detectar mutaciones en el gen PI3KCA (PIK3CA) humano
CN103773837A (zh) * 2013-06-25 2014-05-07 宁波有成生物医药科技有限公司 一种pik3ca基因突变荧光定量pcr检测试剂盒及检测方法
RU2549682C1 (ru) * 2013-10-21 2015-04-27 Общество с ограниченной ответственностью "БИОЧИП-ИМБ" Способ анализа соматических мутаций в гене pi3k с использованием lna-блокирующей мультиплексной пцр и последующей гибридизацией с олигонуклеотидным биологическим микрочипом (биочипом)
US20170044622A1 (en) * 2014-04-18 2017-02-16 Blueprint Medicines Corporation Pik3ca fusions
CN105274188A (zh) * 2014-05-29 2016-01-27 北京雅康博生物科技有限公司 Pik3ca基因突变检测试剂盒
US12391985B2 (en) 2014-08-07 2025-08-19 Pharmassist Ltd Method of determining PIK3CA mutational status in a sample
PT3198026T (pt) * 2014-08-07 2020-01-16 Pharmassist Ltd Método de determinação do estado mutacional de pik3ca numa amostra
US10276072B2 (en) * 2014-09-03 2019-04-30 Washme Properties, Llc Illuminated sign
CN105441533B (zh) * 2014-11-29 2019-07-05 上海赛安生物医药科技有限公司 Pik3ca基因突变检测体系及其试剂盒
CN104531875A (zh) * 2014-12-30 2015-04-22 宁波有成生物医药科技有限公司 一种MyD88基因突变荧光定量PCR检测试剂盒及检测方法
WO2025110738A1 (ko) * 2023-11-24 2025-05-30 주식회사 캐니캐티케어 반려동물의 pik3ca 유전자 돌연변이성 종양 검출용 조성물 및 이를 이용한 반려동물의 pik3ca 유전자 돌연변이성 종양 진단방법
KR20250078789A (ko) 2023-11-24 2025-06-04 주식회사 캐니캐티케어 반려동물의 pik3ca 유전자 돌연변이성 종양 검출용 조성물 및 이를 이용한 반려동물의 pik3ca 유전자 돌연변이성 종양 진단방법

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE61148B1 (en) 1988-03-10 1994-10-05 Ici Plc Method of detecting nucleotide sequences
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
GB9208135D0 (en) 1992-04-13 1992-05-27 Ludwig Inst Cancer Res Polypeptides having kinase activity,their preparation and use
US5846824A (en) 1994-02-07 1998-12-08 Ludwig Institute For Cancer Research Polypeptides having kinase activity, their preparation and use
US6274327B1 (en) 1992-04-13 2001-08-14 Ludwig Institute For Cancer Research Polypeptides having kinase activity, their preparation and use
US20030225013A1 (en) * 2002-05-31 2003-12-04 Isis Pharmaceuticals Inc. Antisense modulation of phosphoinositide-3-kinase, regulatory subunit 4, p150 expression
US5847972A (en) 1993-09-24 1998-12-08 Eick; Stephen Gregory Method and apparatus for graphically analzying a log-file
US6043062A (en) 1995-02-17 2000-03-28 The Regents Of The University Of California Constitutively active phosphatidylinositol 3-kinase and uses thereof
US5948664A (en) 1996-02-29 1999-09-07 The Regents Of The University Of California PI 3-kinase polypeptides
AU735357B2 (en) * 1996-11-01 2001-07-05 Onyx Pharmaceuticals, Inc. Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof
US6277563B1 (en) 1997-01-16 2001-08-21 The Regents Of The University Of California Genetic alterations associated with cancer
US5955277A (en) 1997-05-05 1999-09-21 Novo Nordisk A/S Mutant cDNA encoding the p85α subunit of phosphatidylinositol 3-kinase
US5994076A (en) * 1997-05-21 1999-11-30 Clontech Laboratories, Inc. Methods of assaying differential expression
US7122373B1 (en) 1998-05-14 2006-10-17 Nuvelo, Inc. Human genes and gene expression products V
US8101349B2 (en) 1997-12-23 2012-01-24 Novartis Vaccines And Diagnostics, Inc. Gene products differentially expressed in cancerous cells and their methods of use II
US6537751B1 (en) 1998-04-21 2003-03-25 Genset S.A. Biallelic markers for use in constructing a high density disequilibrium map of the human genome
GB9812768D0 (en) * 1998-06-13 1998-08-12 Zeneca Ltd Methods
US6274237B1 (en) * 1999-05-21 2001-08-14 Chisso Corporation Potentially crimpable composite fiber and a non-woven fabric using the same
AU781151B2 (en) * 1999-10-26 2005-05-12 Immusol Incorporated Ribozyme therapy for the treatment of proliferative skin and eye diseases
US6812339B1 (en) * 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
WO2002027028A1 (en) 2000-09-28 2002-04-04 Atairgin Technologies, Inc. A method of determining tumor characteristics by determining abnormal copy number or expression level of lipid-associated genes
USH2191H1 (en) * 2000-10-24 2007-06-05 Snp Consortium Identification and mapping of single nucleotide polymorphisms in the human genome
CN1358850A (zh) * 2000-12-13 2002-07-17 上海博德基因开发有限公司 一种新的多肽——人磷脂酰肌醇3(PtdIns 3)－激酶17.6和编码这种多肽的多核苷酸
CA2372542A1 (en) 2001-02-20 2002-08-20 Pfizer Products Inc. Transgenic animals containing a dominant negative mutant form of the p85 subunit of pi-3 kinase
US20030162174A1 (en) * 2001-06-11 2003-08-28 Sutherland John W. Detecting nucleic acid deletion sequences
WO2003025175A2 (fr) * 2001-09-17 2003-03-27 Molecular Engines Laboratories Sequences impliquees dans les phenomenes de suppression tumorale, reversion tumorale, apoptose et/ou resistance aux virus et leur utilisation comme medicaments
US20030182669A1 (en) 2002-03-19 2003-09-25 Rockman Howard A. Phosphoinositide 3-kinase mediated inhibition of GPCRs
US7955800B2 (en) 2002-06-25 2011-06-07 Advpharma Inc. Metastasis-associated gene profiling for identification of tumor tissue, subtyping, and prediction of prognosis of patients
CA2491023A1 (en) * 2002-07-19 2004-01-29 Althea Technologies, Inc. Strategies for gene expression analysis
US7217807B2 (en) * 2002-11-26 2007-05-15 Rosetta Genomics Ltd Bioinformatically detectable group of novel HIV regulatory genes and uses thereof
RU2240350C1 (ru) * 2003-03-11 2004-11-20 НИИ онкологии им. проф. Н.Н.Петрова Минздрава РФ Способ идентификации генных мутаций и полиморфизмов
US20070054278A1 (en) 2003-11-18 2007-03-08 Applera Corporation Polymorphisms in nucleic acid molecules encoding human enzyme proteins, methods of detection and uses thereof
SI3296407T1 (sl) 2004-03-02 2019-09-30 The Johns Hopkins University Mutacije gena PIK3CA pri rakih pri ljudeh
CA2566257A1 (en) * 2004-05-07 2005-11-24 Applera Corporation Genetic polymorphisms associated with vascular diseases, methods of detection and uses thereof
WO2005116265A2 (en) * 2004-05-26 2005-12-08 Wyeth Probe arrays for expression profiling of rat genes
US7981605B2 (en) 2005-02-24 2011-07-19 Amgen Inc. Epidermal growth factor receptor mutations
WO2006094149A2 (en) 2005-03-01 2006-09-08 Exact Sciences Corporation Methods and compositions for detecting adenoma
CN103889006B (zh) * 2005-03-14 2017-09-15 皇家飞利浦电子股份有限公司 区分服务的无线网络中的QoS测量和监视
GB2424886A (en) * 2005-04-04 2006-10-11 Dxs Ltd Polynucleotide primers against epidermal growth factor receptor and method of detecting gene mutations
DK1948816T3 (da) 2005-10-24 2012-04-02 Univ Johns Hopkins Forbedrede fremgangsmåder til beaming
JP4477575B2 (ja) * 2005-12-14 2010-06-09 株式会社日立製作所 大腸がんの検査に使用する遺伝子セット
WO2007106407A2 (en) 2006-03-10 2007-09-20 Wyeth Microarray for monitoring gene expression in multiple strains of streptococcus pneumoniae
GB2453173A (en) 2007-09-28 2009-04-01 Dxs Ltd Polynucleotide primers
CA2707539A1 (en) 2007-12-03 2009-06-11 Santaris Pharma A/S Rna antagonist compounds for the modulation of pik3ca expression

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10190171B2 (en) 2007-09-28 2019-01-29 Qiagen Manchester Limited Polynucleotide primers for detecting PIK3CA mutations
US10196692B2 (en) 2007-09-28 2019-02-05 Qiagen Manchester Limited Polynucleotide primers for detecting PIK3CA mutations

Also Published As

Publication number Publication date
EP2239341B1 (en) 2015-01-14
ES2622885T3 (es) 2017-07-07
EP2505673A1 (en) 2012-10-03
CN103834724B (zh) 2016-05-25
US20160040255A1 (en) 2016-02-11
EP2508624B1 (en) 2015-01-14
KR20100101070A (ko) 2010-09-16
KR101548758B1 (ko) 2015-09-01
EP2505671B1 (en) 2017-02-01
CN103695558B (zh) 2016-01-20
ES2532225T3 (es) 2015-03-25
US10190171B2 (en) 2019-01-29
EP2505672B1 (en) 2015-01-14
AU2008303400B2 (en) 2013-09-26
WO2009040557A3 (en) 2009-05-14
KR101543215B1 (ko) 2015-08-07
CA2700710A1 (en) 2009-04-02
CN102119222A (zh) 2011-07-06
GB2453173A (en) 2009-04-01
KR20150038660A (ko) 2015-04-08
BRPI0817444A2 (pt) 2015-06-16
AU2008303400A1 (en) 2009-04-02
US20110027779A1 (en) 2011-02-03
CA2700710C (en) 2018-08-21
US20140141425A1 (en) 2014-05-22
GB0719034D0 (en) 2007-11-07
RU2010116772A (ru) 2011-11-10
EP2239341A1 (en) 2010-10-13
KR101543214B1 (ko) 2015-08-07
WO2009040557A2 (en) 2009-04-02
JP2010539920A (ja) 2010-12-24
US9863003B2 (en) 2018-01-09
RU2491289C2 (ru) 2013-08-27
CA3010064A1 (en) 2009-04-02
US20160032408A1 (en) 2016-02-04
ES2531055T3 (es) 2015-03-10
KR20150038659A (ko) 2015-04-08
CN102119222B (zh) 2015-11-25
EP2205760B1 (en) 2012-06-27
EP2505671A1 (en) 2012-10-03
ES2532141T3 (es) 2015-03-24
CN103834724A (zh) 2014-06-04
CN103952466B (zh) 2016-07-06
CN103695558A (zh) 2014-04-02
KR20150038661A (ko) 2015-04-08
EP2236627A8 (en) 2010-12-01
EP2205760A2 (en) 2010-07-14
EP2505672A1 (en) 2012-10-03
EP2239341A8 (en) 2010-12-01
EP2236627A1 (en) 2010-10-06
EP2236627B1 (en) 2015-01-14
JP5719593B2 (ja) 2015-05-20
US10196692B2 (en) 2019-02-05
ES2620289T3 (es) 2017-06-28
EP2508624A1 (en) 2012-10-10
EP2505673B1 (en) 2017-02-01
US8901285B2 (en) 2014-12-02
ES2531994T3 (es) 2015-03-23
CN103952466A (zh) 2014-07-30
KR101543216B1 (ko) 2015-08-07

Similar Documents

Publication Publication Date Title
MX2010003486A (es) Cebadores de polinucleotido.
WO2011083996A3 (en) Primers for diagnosing ankylosing spondylitis, and method for diagnosing ankylosing spondylitis using the same
WO2008147887A8 (en) Methods and kits for linking polymorphic sequences to expanded repeat mutations
NZ600376A (en) Elite event ee-gm3 and methods and kits for identifying such event in biological samples
WO2013083264A8 (en) Dna polymerases with improved activity
JP2015512251A5 (es)
WO2013083263A8 (en) Dna polymerases with improved activity
PH12015501176B1 (en) Primers, snp markers and method for genotyping mycobacterium tuberculosis
Boukerb et al. Genome sequences of three strains of the Pseudomonas aeruginosa PA7 clade
EP2570492A3 (en) Method for detecting mutations at genes IL28B (RS8099917) and ITPA (RS1127354)
NZ602920A (en) Kras primers and probes
CN101580829B (zh) 一种基因定点多位点突变的方法
WO2006106316A3 (en) Polynucleotide primers
PL1730315T3 (pl) Polimorfizmy w genie NOD2/CARD15
WO2011042901A8 (en) Brucella phage polynucleotides and uses thereof
Poehlein et al. Complete genome sequence of amino acid-utilizing Eubacterium acidaminophilum al-2 (DSM 3953)
RU2008149510A (ru) Набор праймеров для использования при детекции дрожжей рода dekkera и дрожжей рода brettanomyces
SG169223A1 (en) Method of detecting acid-fast bacteria using ribosomal rna as target
RU2013103980A (ru) Способ проведения пцр-пдрф для генотипирования крупного рогатого скота по аллелям а и к гена dgat1
WO2009140679A3 (en) Genetic alterations on chromosomes 21q, 6q and 15q and methods of use thereof for the diagnosis and treatment of type i diabetes
Fatahi et al. Molecular identification of Candida albicans isolated from the oncology patients at four university hospitals in Mazandaran province (2005-6)
WO2004102149A3 (en) Methods and compositions for the detection of bacterial species
WO2010129656A3 (en) Method of oligonucleotide labeling using cycloaddition reaction
RU2009139324A (ru) Биочип для определения мутаций в гене галактоза-1-фосфат-уридил трансферазы, вызывающих поражение печени у новорожденных детей
WO2007115344A8 (en) Set of oligonucleotides

Legal Events

Date Code Title Description
HC Change of company name or juridical status
FG Grant or registration